Last reviewed · How we verify
Hydroxycarbamide film-coated tablet — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Hydroxycarbamide film-coated tablet (Hydroxycarbamide film-coated tablet) — Theravia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hydroxycarbamide film-coated tablet TARGET | Hydroxycarbamide film-coated tablet | Theravia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hydroxycarbamide film-coated tablet CI watch — RSS
- Hydroxycarbamide film-coated tablet CI watch — Atom
- Hydroxycarbamide film-coated tablet CI watch — JSON
- Hydroxycarbamide film-coated tablet alone — RSS
Cite this brief
Drug Landscape (2026). Hydroxycarbamide film-coated tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/hydroxycarbamide-film-coated-tablet. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab